profiles bristol-myers-squibb-company 
3BL Media
MAY 19, 2022
SOURCE: Bristol Myers Squibb Company. Schoenfeld: For me, I’ve been so excited to see how we can potentially provide patients with new and even chemotherapy-free options that offer clear clinical benefits, and similarly, how we can now molecularly profile a patient’s tumor and target vulnerabilities and mutations.
GreenBiz
MAY 8, 2021
From how businesses chose to respond to the COVID-19 pandemic to the escalating outcry over racial justice to the increasing urgency around climate change, there is much for companies to answer for this year. And what could that mean for a corresponding evolution in how companies manage, measure and disclose their ESG risks and efforts?
Expert insights. Personalized for you.
130 
Let's personalize your content